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Abstract
Phospholipid (PL) scramblase is a 35 kDa protein that is thought to mediate Ca2-induced bidirectional transbilayer
movement of plasma membrane phospholipids in activated, injured, or apoptotic cells. We recently reported the molecular
cloning of a PL scramblase of human (HuPLSCR1) and mouse origin, respectively. In the present study, the gene for
HuPLSCR1 was cloned from a human genomic library. The gene size is 29.7 kb and includes nine exons. Analysis of the 5P
flanking genomic sequence with luciferase reporter constructs located the promoter to a region spanning from 395 to +60 of
the first (untranslated) exon. Furthermore, we report the molecular cloning of three additional novel cDNAs encoding
proteins with high homology to HuPLSCR1. The predicted open reading frames encode proteins with 59% (HuPLSCR2; 224
aa), 47% (HuPLSCR3; 295 aa) and 46% (HuPLSCR4; 329 aa) identity, respectively, to HuPLSCR1. All members of the
PLSCR gene family conserve those residues contained in the segment of the PLSCR1 polypeptide that was previously shown
to bind Ca2. With the exception of HuPLSCR2, these proteins also each contain multiple PXXP motifs and a PPXY motif
located near the N-terminus, implying the potential for interaction with SH3 or WW domain-containing proteins,
respectively. HuPLSCR1, 2, and 4 were found to be closely clustered on chromosome 3 (3q23), whereas HuPLSCR3 is
located on chromosome 17. Northern blots revealed that the expression of HuPLSCR2 is restricted to testis, whereas
HuPLSCR1, 3 and 4 are expressed in most of the 16 tissues examined. Notable exceptions were HuPLSCR4, which was not
detected in peripheral blood lymphocytes, and HuPLSCR1 and HuPLSCR3, which were not detected in brain. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Introduction
While aminophospholipids are primarily found in
the inner lea£et of the plasma membrane of a resting
cell, surface exposure of phosphatidylserine (PS) is
observed in activated, injured or apoptotic cells
[1,2]. Surface-exposed PS plays a central role in pro-
moting blood coagulation, as this lipid serves as as-
sembly site for coagulation factors, including the
prothrombinase and tenase enzyme complexes. Ami-
nophospholipids have also been implicated as a sig-
nal in the clearance of apoptotic or activated cells
through phagocytosis [1,3^7]. This redistribution of
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plasma membrane phospholipids (PLs) appears to be
mediated by an increase in intracellular Ca2, is bi-
directional, and is independent of the PL headgroup
[1,8^10]. Although the exact mechanisms involved
remain to be elucidated, we recently cloned and ex-
pressed a protein, termed phospholipid scramblase
(HuPLSCR1), which when reconstituted into lipo-
somes exhibits many of the characteristics observed
for the Ca2-induced surface exposure of PS in cells
[11,12]. HuPLSCR1 was found to be expressed in a
wide range of tissues, and the level of expression
appeared to correlate with the observed Ca2-in-
duced redistribution of PS [12,13]. We subsequently
cloned a murine orthologue (herein termed
MuPLSCR2), which when reconstituted into proteo-
liposomes promoted Ca2-mediated PL scramblase
activity [14]. A second murine orthologue, termed
MmTRA1b, was recently reported [15]. Whereas
PL scramblase activity was not demonstrated for
that protein, multiple sequence alignment of the pre-
dicted open reading frames revealed that it, rather
than MuPLSCR2, may be the true murine ortho-
logue of HuPLSCR1. This prompted a search for
additional homologues of HuPLSCR1. Here we re-
port the molecular cloning of cDNAs encoding three
novel proteins with high homology to human
PLSCR1, suggesting that they belong to the same
gene family. The size and tissue distribution of
mRNA transcripts for the di¡erent HuPLSCR fam-
ily members are compared. We also describe the gene
structure of HuPLSCR1 and analyze its promoter
region.
2. Materials and methods
2.1. Cloning of human PL scramblase 1 gene
A BAC human genomic library (Genome System
Inc., St. Louis, MO) was screened with a 1.445 kb
HuPLSCR1 cDNA probe (GenBank accession num-
ber AF098642) by hybridization. A positive clone of
approximately 100 kb was obtained, digested with
EcoRI, and the fragments were cloned into pcDNA3
(Invitrogen). Subclones were identi¢ed by hybridiza-
tion with digoxigenin-labeled HuPLSCR1 cDNA
probe, and DNA inserts were sequenced on an ABI
DNA Sequencer Model 373 Stretch (Applied Biosys-
tems) using the Prism Ready Reaction DyeDeoxy
Terminator Cycle Sequencing Kit (Perkin Elmer).
2.2. Construction of 5P £anking region deletions of
PLSCR1 gene
A 4180 bp DNA fragment consisting of the 5P
£anking region (0 to 34120) and the ¢rst 60 bp of
the ¢rst exon (+1 to +60) of the HuPLSCR1 gene
(GenBank accession number AF153715) was cloned
into pGL3 basic luciferase reporter vector (Prome-
ga). In order to identify the promoter region of the
gene, the 5P £anking DNA was serially deleted both
from the 5P and the 3P end by PCR-mediated deletion
and cloned into pGL3 basic luciferase reporter vector
for analysis.
2.3. Cell culture and transfection of Daudi cells
The Burkitt’s B cell lymphoma cell line Daudi was
cultured in RPMI 1640 complete medium with 20%
fetal bovine serum, 100 U of penicillin/ml, and 100
Wg of streptomycin/ml, at 37‡C, 5% CO2. Cells were
washed and suspended to 1.35U107/ml in Opti-
MEM. To 0.8 ml of cell suspension in a 0.4 cm
electroporation cuvette, 20 Wg of pGL3 5P £anking
region or deletions of HuPLSCR1 and 20 Wg of pSV
L-galactosidase (Promega) were added. The mixture
was incubated for 10 min on ice, and electroporated
at 380 V and 500 WF using a Bio-Rad Gene Pulser II
(Bio-Rad). After incubation for 10 min at 37‡C the
cells were plated in 10 ml of RPMI complete me-
dium. Forty-eight hours later, transfected cells were
harvested for luciferase and L-galactosidase assay.
2.4. Luciferase and L-galactosidase assay
Luciferase activity was measured with a Luciferase
Assay Kit (Promega). In brief, transfected Daudi
cells were harvested, washed with phosphate-bu¡ered
saline and lysed for 15 min with Reporter lysis bu¡-
er. The cell lysate was vortexed for 15 s and centri-
fuged at 12 000Ug at 4‡C for 2 min. In a 96-well
plate, 20 Wl of lysate was mixed with 100 Wl of lucif-
erase assay bu¡er by automated reagent injection
using a MicroLumatPlus microplate luminometer
(EG and G Berthold), and luminescence was meas-
ured for 30 s. L-Galactosidase activity was deter-
BBAMEM 77897 27-7-00
T. Wiedmer et al. / Biochimica et Biophysica Acta 1467 (2000) 244^253 245
mined with o-nitrophenyl-L-D-galactopyranoside as
substrate. 100 Wl of cell lysate was incubated with
100 Wl of 4.4 mM o-nitrophenyl-L-D-galactopyrano-
side for 1 h at 37‡C, and absorbance was read at 420
nm. Luciferase activity was expressed in arbitrary
light units, and corrected for transfection e⁄ciency
of L-galactosidase.
2.5. Cloning of PL scramblase family members
BLAST search of the GenBank database of ex-
pressed sequence tags (EST) with HuPLSCR1
cDNA identi¢ed three distinct clusters of EST clones
each displaying overlapping identities. Appropriate
EST clones were obtained from American Type Cul-
ture Collection, sequenced, and the information was
used to design PCR primers speci¢c for the 3P and 5P
ends of the various homologues. Full-length cDNAs
were obtained by PCR using a human erythroleuke-
mia cell (HEL) cDNA library (Clontech; for
HuPLSCR2 and HuPLSCR3) or human multiple tis-
sue cDNA (Clontech; for HuPLSCR2 and
HuPLSCR4) as template. Each PCR reaction and
cloning was performed in triplicate, and Advantage
HF2 DNA polymerase mix (Clontech) was used to
decrease PCR-mediated error. PCR products were
cloned into pCR2.1 (Invitrogen) for sequencing. Se-
quence of the coding region was con¢rmed in at least
two independent clones for each of the family mem-
bers. For HuPLSCR2, identical sequence was found
in HEL, and multiple tissue cDNA from heart, pan-
creas and liver. For HuPLSCR3, the two clones se-
quenced from HEL were identical, and con¢rmed in
a number of EST clones. For HuPLSCR4, sequence
was obtained using multiple tissue cDNA from pan-
creas, spleen, and heart. Polymorphisms were noted
in two positions for HuPLSCR4, as noted in the
legend to Fig. 4.
2.6. Chromosomal mapping
The chromosomal location for HuPLSCR2 was
determined using the GeneBridge 3 Human Radia-
tion hybrid panel and oligonucleotides 5P-CCTGGT-
GCTTAGGGTAGACAATATG-3P and 5P-CTGAC-
GTCCTGGGTAGAAGGCCTGGG-3P as the for-
ward and reverse primers, respectively (Research Ge-
netics, Huntsville, AL). The primers £ank a small
intron (88 bp) within the 5P untranslated region of
HuPLSCR2, giving a PCR product of 314 bp. The
map position was calculated using the Stanford serv-
er (http://www.shgc.stanford.edu).
2.7. Tissue distribution
Human multi-tissue Northern blots (Clontech)
were hybridized with random prime labeled cDNA
probes of HuPLSCR1, 2, and 4. The HuPLSCR1
probe consisted of nucleotides 1^498 of HuPLSCR1
(GenBank AF098642). The HuPLSCR2 probe (nu-
cleotides 1^1265 of GenBank AF159441) was pre-
pared by digesting EST clone AA813518 with NotI
and XhoI, and the HuPLSCR4 probe (nucleotides 1^
851 of GenBank AF199023) by digesting EST clone
N78598 with NotI and XhoI. The cDNA fragments
were separated from vector sequences by agarose gel
electrophoresis and puri¢ed using Wizard columns
(Promega). The cDNA probes were labeled with
[K-32P]dATP (50 WCi/25 ng cDNA, 3000 Ci/mmol;
ICN) using the random prime labeling kit from
Boehringer Mannheim to a speci¢c activityv 1U109
dpm/Wg. Due to non-speci¢c hybridization of the
cDNA probe, an RNA antisense probe was designed
for HuPLSCR3. A PCR product of the 3P untrans-
lated region of HuPLSCR3 (nucleotides 1044^1279
of GenBank AF159442) was prepared using the for-
ward primer 5P-TGTGAGGAGACCATCACCTCG-
AC-3P and reverse primer 5P-AAAGCTGATATGC-
CTGTGTGCC-3P. The reverse primer contained the
T7 promoter sequence (5P-AATTTAATACGACT-
CACTATAGGG-3P) at the 5P end. The PCR prod-
uct was puri¢ed using the Qiaquick PCR puri¢cation
kit (Qiagen). A 32P-labeled antisense RNA probe was
prepared using 50 ng of the PCR product as template
in T7 transcription reaction with [K-32P]UTP (800 Ci/
mmol, 20 WCi/Wl ; Amersham) following the instruc-
tions included in the T7 Strip-EZ RNA kit (Am-
bion). Multi-tissue Northern blots were prehybrid-
ized for 1 h at 68‡C in ExpressHyb hybridization
bu¡er (Clontech) followed by hybridization for 18
h at 68‡C in the same bu¡er containing 2U106
cpm/ml denatured random prime labeled probe.
For HuPLSCR3, the blots were prehybridized in Ul-
traHyb hybridization bu¡er (Ambion) with 100 Wg/
ml denatured salmon sperm DNA and 50 Wg/ml
yeast RNA and hybridized in the same bu¡er con-
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taining 32P-labeled antisense RNA probe (2U106
cpm/ml) at 68‡C for 18 h. The blots were washed
at a ¢nal stringency of 0.1USSC in 0.1% SDS at
50‡C (68‡C for HuPLSCR3), and exposed to Amer-
sham Hyper¢lm MP.
3. Results and discussion
3.1. Human PLSCR1 gene structure
In order to gain insight into the gene organization
of HuPLSCR1, a clone of approximately 100 kb of
genomic DNA was obtained from a BAC human
genomic library by screening with a HuPLSCR1
cDNA probe. EcoRI-digested fragments were cloned
into pcDNA3, and sequence from six di¡erent clones
was used to deduce 29.7 kb of HuPLSCR1 genomic
DNA. The organization of the gene was deduced by
alignment of the genomic sequence with the cDNA
sequence for HuPLSCR1 (GenBank accession num-
ber AF098642). The HuPLSCR1 gene consists of
nine exons, eight introns and 5P £anking sequence
(deposited under GenBank accession numbers
AF153715 and AF224492). As shown in Table 1,
invariant gt and ag were found at the intron splice
donor and acceptor sites. As illustrated in Fig. 1, the
¢rst exon is untranslated, with the open reading
frame starting in exon 2. Of interest, Kasukabe et
al. [16] reported the occurrence of a truncated form
of MuPLSCR1 (termed MmTRA1a), the closest
murine orthologue of HuPLSCR1, in a mouse mono-
cytic cell line which was highly leukemogenic when
injected into syngeneic or athymic mice. In addition,
non-leukemogenic sublines became leukemogenic
when transfected with MmTRA1a. By contrast, nor-
mal macrophages expressed only full-length
MuPLSCR1. Comparison of the sequence of
MmTRA1a with Fig. 1 reveals that murine
MmTRA1a is likely a product of alternative splicing,
as the predicted open reading frame reported by Ka-
sukabe et al. [16] starts at a position corresponding
to the beginning of exon 6 in HuPLSCR1. It remains
to be determined whether the analogous alternatively
spliced forms of HuPLSCR1 are similarly associated
with leukemias in man.
3.2. Promoter analysis
In order to identify the promoter region for
HuPLSCR1, luciferase reporter constructs of 5P
£anking sequence and serial 5P or 3P deletions were
expressed in Daudi cells, which normally express the
HuPLSCR1 gene. As illustrated by the data in Fig.
2, a reporter construct containing 5P untranslated se-
quence comprised of 34120 to +60 exhibited strong
promoter activity. Deletion of sequence from the 5P
end from 34120 bp to 3557 bp did not a¡ect pro-
moter activity. However, deletion from 395 bp of 5P
£anking sequence to +60 bp of the ¢rst (untrans-
lated) exon resulted in the loss of more than 97%
of promoter activity, locating the promoter of
HuPLSCR1 to that region. Computer analysis of
HuPLSCR1 5P £anking sequence using the MatIns-
pector V2.2 program (http://www.gsf.de/biodv/mat-
inspector.html) revealed two GC boxes (TAGGG-
GAGGGGCCT at 379 to 366 bp, and AGG-
AGGTGGGCGCA at 359 to 346 bp) and a
Table 1
DNA sequence at the exon and intron junctions of HuPLSCR1 gene
Splice donor site Splice acceptor site
Exon 1 AGCCAGAGgtgcgcgg Intron 1 tttttcagAACTGTTT Exon 2
Exon 2 CAAACAAAgtaagtaa Intron 2 aattgcagACTCACAG Exon 3
Exon 3 ATTCCAAGgtaaagca Intron 3 tatttcagGACCTCCA Exon 4
Exon 4 TAAGTCAGgtaatttc Intron 4 tgctatagATAGATCA Exon 5
Exon 5 TCTGGAAGgtatgtat Intron 5 gtttttagTTTTAACA Exon 6
Exon 6 TTCAGGAGgtctgtga Intron 6 ctttgtagATAGAAAT Exon 7
Exon 7 ATTTTGAGgtaagaga Intron 7 caatttagATTAAATC Exon 8
Exon 8 TCCTCATTgtaagtct Intron 8 ttatctagGACTTCAT Exon 9
Exon sequence is shown in uppercase, intron sequence in lowercase letters. The invariant gt of intron at the splice donor site and ag
of intron at the splice acceptor site are shown in bold.
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CCAAT box (TCTCTCCAATG at 3111 to 3101
bp) (Fig. 3), consistent with the data in Fig. 2 locat-
ing promoter activity to that region. In addition,
potential binding sites for transcriptional activators,
including activator protein 4 (AP4), upstream stim-
ulating factor (USF), eukaryotic transcriptional reg-
ulator 1 (ETS1), interferon-stimulated response ele-
ment (ISRE), and interferon regulatory factor (IRF),
were identi¢ed. We had previously identi¢ed the sin-
gle ISRE that is located in the ¢rst untranslated exon
Fig. 1. Gene structure of the HuPLSCR1 gene. (Top) Schematic showing location of intron^exon borders within the HuPLSCR1 ge-
nomic sequence of 29.7 kb. Exons are represented by vertical lines. (Below) cDNA sequence of HuPLSCR1 as previously described
by Zhou et al. [12] and deposited in GenBank under accession number AF098642. Locations of exons within the cDNA are indicated
by arrows. Genomic sequence for HuPLSCR1 deposited in GenBank under accession number AF224492.
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(+21 to +35) as the primary site responsible for the
upregulation of HuPLSCR1 by interferon-K in Dau-
di and a variety of other cells [17].
3.3. Identity of a novel PL scramblase gene family
As previously reported, HuPLSCR1 does not
show signi¢cant homology to any other known hu-
man protein, and no signi¢cant consensus to identi-
¢able protein family or domain structures [12]. How-
ever, upon performing BLAST searches of the
GenBank EST database with HuPLSCR1, we noted
three distinct clusters of EST clones that were sim-
ilar, but distinctly di¡erent from the sequence we had
originally reported for HuPLSCR1. In order to ob-
tain cDNAs for these putative homologues of
HuPLSCR1, sequence derived from relevant EST
clones was used to design PCR primers. Full-length
cDNAs were obtained by PCR using a cDNA library
from HEL cells, and cDNA from multiple human
tissues as template. As illustrated in Fig. 4, the
cloned cDNAs encode three novel proteins with
high homology to HuPLSCR1. The predicted open
reading frames encode proteins with 59%
(HuPLSCR2; 224 aa; GenBank AF159441), 47%
(HuPLSCR3; 295 aa; GenBank AF159442) and
46% (HuPLSCR4; 329 aa; GenBank AF199023)
identity, respectively, to HuPLSCR1. Furthermore,
cDNAs of novel murine orthologues of HuPLSCR3
(MuPLSCR3; 327 aa; GenBank AF159850) and
HuPLSCR4 (MuPLSCR4; partial, in progress)
have been cloned and sequenced (data not shown).
Closer inspection of the four human PLSCR homo-
logues reveals a low degree of similarity for the pro-
line-rich amino-terminal portion of the proteins
(amino acids 1^85 in HuPLSCR1), and highest de-
gree of identity towards the carboxy-terminus, in-
cluding a region (aa 273^284 in HuPLSCR1) which
has been shown for HuPLSCR1 to contain a Ca2
binding site required for the Ca2-induced trans-
membrane movement of phospholipids [14]. Of
note, the predicted open reading frame for
HuPLSCR2, the closest homologue to HuPLSCR1,
is missing the proline-rich amino-terminus that is
Fig. 3. Analysis of genomic 5P £anking sequence of HuPLSCR1. Shown are consensus promoters and putative binding sites for tran-
scriptional activators in 5P £anking sequence and ¢rst untranslated exon of HuPLSCR1 gene (GenBank accession number AF153715)
as predicted by MatInspector V2.2.
Fig. 2. E¡ect of 5P and 3P deletion of 5P £anking region of
HuPLSCR1 gene on promoter activity. 5P £anking DNA was
serially deleted from either the 5P end or the 3P end by PCR,
and intact (34120 bp to +60 bp) or the truncated DNA cloned
into pGL3 luciferase reporter vector. Daudi cells were trans-
fected with pGL3 constructs and pSV L-galactosidase, and har-
vested 48 h later for assay of luciferase and L-galactosidase ac-
tivity. pGL3 vector (without insert) served as control (see
Section 2). Data are expressed as ratio luciferase/L-galactosidase
activity. Data of three experiments.
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characteristic for all other members of this family. As
pointed out previously for HuPLSCR1, this region
(aa 1^85 in HuPLSCR1) contains a number of
PXXP motifs, which may serve as potential binding
sites for proteins containing SH3 domains [15,18].
PXXP motifs are also found in the corresponding
segments of HuPLSCR3 and 4. In addition,
HuPLSCR1, 3, and 4 all contain one or more
PPXY motifs in that same region (aa 22^25 and aa
33^36 in HuPLSCR1; aa 15^18 in HuPLSCR3; aa
30^33 in HuPLSCR4), suggesting a potential inter-
action with proteins containing WW domains [19].
Such domains are primarily found in proteins with
signaling or regulatory function. Although binding
partners for any of the PLSCR proteins have not
been identi¢ed to date, it is interesting to note that
the functional implication of the missing amino-ter-
minal segment in HuPLSCR2 may be a potential loss
of interaction with an adapter or signaling molecule.
A similar truncation has previously been noted to
confer leukemogenic potential to MuPLSCR1
(MmTRA1a) [15,16].
3.4. Chromosomal assignment of PL scramblase
family members
The chromosomal locations of HuPLSCR1,
HuPLSCR3 and HuPLSCR4 were determined from
Fig. 4. Alignment of amino acid sequences of four HuPLSCR homologues. Alignment was performed using Clustal W [20]. Identical
amino acids are shown on a black, and conservative substitutions on a gray background. cDNA sequences deposited in GenBank
under the following accession numbers: HuPLSCR1 (human phospholipid scramblase), AF098642; HuPLSCR2, AF159441;
HuPLSCR3, AF159442; HuPLSCR4, AF199023. For HuPLSCR4, sequence obtained for cDNA from pancreas is shown. In sequen-
ces from other tissues, nucleotides were A at position 246 and A at position 608 of the cDNA, changing Ser34 to Asn, and Val155 to
Ile, respectively.
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nucleotide sequence homologies to STS sequences
found on the NCBI Human Gene Map’99 (http://
www.ncbi.nlm.nih.gov/genemap/). The genes for
HuPLSCR1 (stSG10277) and HuPLSCR4 (GenBank
N78598/G37067) are clustered between markers
D3S1557 and D3S1306 (164.6^168.3 cM) on chro-
mosome 3 (3q23) at the physical position 537.09
cR3000. HuPLSCR1 has also been independently
mapped to chromosome 3 at 3q23 by £uorescence
in situ hybridization [15]. A partial sequence for
the HuPLSCR3 gene is located between nucleotides
10 501 and 9174 of the gene sequence deposited in
GenBank under accession number AF097738, which
also encodes a non-receptor tyrosine kinase gene (nu-
cleotides 531^9180). The non-receptor tyrosine ki-
nase gene has been localized to chromosome
17p13.1 between markers D17S1828 and D17S786
(9.8^18.1 cM) at the physical position 53.50 cR3000,
thus localizing HuPLSCR3 to that position. The
gene for HuPLSCR2 was mapped as described in
Section 2, and was found to be located on chromo-
some 3 (3q23), closely clustered with HuPLSCR1
and HuPLSCR4. The phylogenetic relationship be-
tween the various PL scramblase gene family mem-
bers of both human and murine origin as analyzed
by the PHYLIP Rooted Phylogenetic Tree program
following multiple sequence alignment using Clustal
W is illustrated in Fig. 5.
3.5. Tissue distribution of PL scramblase family
members
The tissue distribution for the four members of the
PL scramblase family of proteins was evaluated by
Northern blotting with 32P-labeled probes speci¢c for
HuPLSCR1^4, respectively. The speci¢city of the
probes was ascertained by DNA dot blot (Fig. 6).
Whereas amounts of mRNA for HuPLSCR2 in
many of these tissues were below the limit of detec-
tion, the mRNAs for the other three homologues
were expressed in most of the 16 di¡erent tissues
examined. However, the expression patterns for these
three family members show distinct di¡erences. Fig.
7 shows that mRNA for HuPLSCR1 was below the
limits of detection in brain and skeletal muscle. As
previously reported, two di¡erent size transcripts
(V2.55 kb and 1.6 kb) were detected for HuPLSCR1
Fig. 6. Probe speci¢city for di¡erent HuPLSCR family mem-
bers. The speci¢city of each probe (to be used for Northern
blots shown in Fig. 7) was tested by hybridization to dot blots
containing two-fold serial dilutions of DNA (0.1 fmol to 1.6
amol) of (1) a pCR2.1 clone containing bases 1^2076 of
HuPLSCR1 (GenBank AF098642), (2) HuPLSCR2 EST clone
AA813518 containing bases 1^1265 of GenBank AF159441, (3)
HuPLSCR3 EST clone AA634048 containing bases 1^1671 of
GenBank AF159442, and (4) a pCR2.1 clone containing bases
1^3206 of HuPLSCR4 (GenBank AF199023). The dot blots
were hybridized with random prime labeled probes for
HuPLSCR1, 2, and 4, and the antisense RNA probe for
HuPLSCR3 described in Section 2. Hybridizations with the ran-
dom prime labeled probes for HuPLSCR1, 2, and 4 (2U106
cpm/ml) were performed in ExpressHyb at 68‡C for 1 h, and
hybridization with the antisense probe for HuPLSCR3 (2U106
cpm/ml) was in UltraHyb bu¡er with 100 Wg/ml denatured sal-
mon sperm DNA and 50 Wg/ml yeast RNA at 68‡C for 18 h.
Blots were washed at a ¢nal stringency of 0.1USSC in 0.1%
SDS at 50‡C, then exposed to ¢lm.
Fig. 5. Phylogenetic tree of human and murine members of the
PL scramblase gene family. Multiple sequence alignment for
protein sequences of human and murine members of the PL
scramblase gene family was performed using Clustal W, and an-
alyzed using the PHYLIP Rooted Phylogenetic Tree program
(http://workbench.sdsc.edu/). GenBank accession numbers for
HuPLSCR1^4 as indicated in Fig. 4. Accession numbers for
murine PLSCR: MuPLSCR1, AF159593; MuPLSCR2,
AF015790; MuPLSCR3, AF159850.
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in all tissues expressing this gene. Kasukabe et al.
have suggested that the di¡erent size transcripts arise
from alternative polyadenylation signals within the
3P untranslated region of the HuPLSCR1 gene
[12,15]. Interestingly, the expression of HuPLSCR2
mRNA appears to be highly restricted. Although
trace amounts of HuPLSCR2 could be ampli¢ed
from HEL cells through several rounds of PCR for
sequencing purposes (see Section 2), a 1.6 kb message
was only detected in testis. This result was con¢rmed
by probing a human Multi Tissue Expression Array
(Clontech, Cat. #7775-1), which again yielded a pos-
itive blot against mRNA of testis only. This blot also
revealed that in addition to the tissues listed in Fig.
7, HuPLSCR2 message was also not detected in any
tissues of the gastrointestinal tract, bladder, ovary,
lymph node, bone marrow, and adrenal, thyroid,
salivary or mammary gland (results not shown).
HuPLSCR3 mRNA was below the limit of detection
in testis, brain or liver. Two sizes of mRNA were
detected with the HuPLSCR3-speci¢c probe: where-
as a V1.8 kb mRNA species was observed for most
tissues, a V2.1 kb mRNA transcript was detected in
skeletal muscle. An mRNA transcript of V4 kb was
detected for HuPLSCR4 in all tissues examined ex-
cept peripheral blood lymphocytes. Importantly,
HuPLSCR4 mRNA was the only family member ex-
pressed at detectable levels in brain tissue. Whether
HuPLSCR1, 3, and 4 have redundant function in a
number of tissues, or whether these proteins exhibit
activities that are distinct for each family member is
the subject of future experimentation.
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